Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Invictus MD

Invictus MD
2014 FOUNDED
PUBLIC STATUS
81-90 EMPLOYEES
GENE STOCK SYMBOL
16 INVESTMENTS
$0.09 SHARE PRICE (As of Tuesday Closing)
Description

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Formerly Known As
BioAB Strategies
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Capital Markets/Institutions
Other Industries
Other Financial Services
Stock Exchange
TSX
Primary Office
  • 595 Burrard Street, Three Bentall Centre
  • Suite 3123
  • Vancouver, British Columbia V7X 1J1
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Invictus MD’s full profile, request a free trial.

Invictus MD Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.08 - $0.94 $11.5M $0.09 -$0.24 144K 125M

Invictus MD Financials Summary

In Thousands,
USD
TTM
31-Oct-2019
FY 2019
31-Jan-2019
FY 2018
31-Jan-2018
FY 2017
31-Jan-2017
Enterprise Value 23,792 84,685 117,216 11,711
Revenue 5,289 3,599 1,831 1,935
EBITDA (25,252) (25,937) (14,646) (4,595)
Net Income (28,426) (27,387) (15,314) (4,280)
Total Assets 94,845 117,077 93,577 15,299
Total Debt 8,905 11,622 0 1,596
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Invictus MD Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Invictus MD‘s full profile, request access.

Request full access to PitchBook

Invictus MD Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 000000 Corporation Toronto, Canada 00 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Invictus MD Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (000 07-Jan-2019 00000 0000000 Pharmaceuticals 000000 000000
00000000 16-Nov-2018 000000000000000000 000.00 Pharmaceuticals 000000 000000
0000 0000 02-Nov-2018 000000000000000000 00.000 Clinics/Outpatient Services 000 0000000
000000 000 000000 31-Aug-2018 000000000000000000 00000 Distributors (Healthcare) 000 0000000
AB Laboratories 27-Mar-2018 Merger/Acquisition 0000 Other Healthcare 000 0000000
To view this company’s complete investment and acquisition history, request access »

Invictus MD Subsidiaries (6)

Company Name Industry Location Founded
Leaf Wise Clinics/Outpatient Services Grande Prairie, Canada 2017
0000000 000000 Holding Companies Canada 0000
00000000 000000 00 Medical Records Systems Vancouver, Canada 0000
000000 0000000 000 Biotechnology Kelowna, Canada 0000
00000000 Pharmaceuticals Delta, Canada 0000
To view this company’s complete subsidiary history, request access »

Invictus MD Executive Team (8)

Name Title Board
Seat
Contact
Info
Gene Simmons Executive
Natasha Collins Executive
Dan Kriznic Founder & Advisor to CEO and Chairman
Larry Heinzlmeir Vice President

4 Former Executives

You’re viewing 4 of 8 executives. Get the full list »

Invictus MD Board Members (3)

Name Representing Role Since Contact
Info
0000 0000000 Self Chairman & Board Member 000 0000
0000000 000 Self Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »